A total of 69 to 80% of the patients who received tirzepatide and 64% of those who received semaglutide had a decrease in the glycated hemoglobin level to 6.5% or less, and 27 to 46% and 19%, respectively, had a decrease in the glycated hemoglobin level to less than 5.7% (Fig
When your infusion is complete, we'll remove the IV line, apply a small bandage, and give you post-treatment recommendations
We're committed to your health journey, and it begins with a personalized evaluation by an expert healthcare provider via a convenient online consultation
Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering the United States
Wikarek A, Grabarczyk M, Klimek K, Janoska-Gawroska A, Suchodolska M, Holecki M
Patients and providers alike can benefit from understanding these broader effects